Federal government gave Moderna $483 million in April to develop vaccine

REMINDER: New “vaccine czar” Moncef Slaoui owns 156,000 stock options in Moderna, a clear conflict of interest

Washington, DC – Patients Over Pharma released the following statement on reports that Moderna’s coronavirus vaccine is showing promising initial results.

“While this is fantastic news that hopefully leads to a successful vaccine, taxpayers deserve some assurances that the nearly $500 million they handed to Moderna will result in a vaccine that is affordable and accessible to every American and not simply another drug company profit engine putting more money into the pockets of shareholders like Trump’s new ‘vaccine czar.’”

###

back to top